Sparsom evidens for antipsykotika til behandling af organisk delirium
| Autor: | Andersen, Charlotte U, Høimark, Lene, Dabrowski, Karol, Hansen, Kenneth Brandt, Sædder, Eva |
|---|---|
| Jazyk: | dánština |
| Rok vydání: | 2014 |
| Předmět: |
Evidence-Based Medicine
Benzodiazepines/therapeutic use Olanzapine Risperidone/therapeutic use Sulpiride/analogs & derivatives Thiazoles/therapeutic use Humans Quetiapine Fumarate/therapeutic use Amisulpride behavioral disciplines and activities Delirium/drug therapy Antipsychotic Agents/therapeutic use Piperazines/therapeutic use |
| Zdroj: | Andersen, C U, Høimark, L, Dabrowski, K, Hansen, K B & Sædder, E 2014, ' Sparsom evidens for antipsykotika til behandling af organisk delirium ', Ugeskrift for Laeger, bind 176, nr. 20, V11130658, s. 1858-1862 . < https://ugeskriftet.dk/videnskab/sparsom-evidens-antipsykotika-til-behandling-af-organisk-delirium > |
| Popis: | Traditionally, haloperidol has been the recommended antipsychotic drug for pharmacological treatment of delirium, which is a frequent complication in the critical care setting. Due to a less frequent occurrence of extrapyramidal adverse effects, second-generation antipsychotic drugs have been evaluated. In the present paper we review the current randomized prospective studies of second-generation antipsychotics as treatment for delirium in hospitalized patients and conclude that so far the evidence in favour of these drugs compared with haloperidol is still sparse. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|